NICOLE ROMINE: Open Payments
NPI 1023663770 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 25 payments from 5 companies in 2025. Trend: 2023 $500 · 2024 $2,344 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 21 | $454 |
| Calliditas Therapeutics US Inc. | 1 | $23 |
| AKEBIA THERAPEUTICS INC | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: Filspari, TARPEYO, Vafseo, Ozempic, JARDIANCE.
Industry payments across MO — which companies pay providers there.
